1
RODENT RISES FROM THE DEAD Mammal is the living representative of a lineage presumed extinct. www.nature.com/news NATURE|Vol 440|16 March 2006 NEWS 263 Huge Biobank project launches despite critics British family doctors have started recruiting subjects for an ambitious effort to probe the interplay of genetic and environmental factors that cause disease. Researchers hope that half a million people will donate blood and urine samples, and give access to their medical records, as part of UK Biobank. This £61-million (US$105-million) project launched on 13 March, funded by the Medical Research Council and the Wellcome Trust. Critics question whether it will give value for money. But the project’s orga- nizers say it has enormous research potential. Participants will be weighed and measured, and answer questions on topics such as alcohol intake and family medical history. Details will be held in a database and linked to records col- lected by the National Health Service (NHS). Thousands of cases of conditions such as heart disease and cancer are likely to develop, and researchers will be able to search the data- base for underlying genes and lifestyle choices. Critics, including members of the House of Commons Select Committee on Science and Technology, say health records alone can be a poor guide to the conditions a person suffers from. Medical journals have asked whether enough cases of disease will develop for results to be statistically meaningful. In contrast to some other genetic-database projects, however, critics are not con- cerned about data-privacy and ethical issues. UK Biobank’s chief executive, Rory Collins, an epidemiologist at the University of Oxford, says complaints stem in part from a misunder- standing of the scheme. It might make sense to study the families of ill people if disease genes were the main target, he says, but they are not. “The primary use will be to compare people who develop disease with those that don’t,” he says. Researchers will then be able to examine the lifestyle and genetic factors that differenti- ate the two groups. Collins estimates that scientists will want to start mining the database in about ten years, when several thousand cases of diseases will have emerged. He adds that changes in the NHS computer system should have made it easier for scientists to use for research by then. Access will be controlled by UK Biobank, which will vet applications and coordinate groups to minimize the cost of accessing sam- ples. These will be frozen and split between two locations, to provide a back-up. The UK project will be tracked in countries with similar schemes. Canada, Iceland and Japan have set up smaller biobanks. Work began in 2001 on a project in Estonia, where the government wants to collect genealogical, health and DNA data on a million citizens — it aims to have data on some 100,000 by 2009. Jim Giles “Complaints stem in part from a misunderstanding of the scheme.” Nature Publishing Group ©2006

Huge Biobank project launches despite critics

  • Upload
    jim

  • View
    215

  • Download
    2

Embed Size (px)

Citation preview

Page 1: Huge Biobank project launches despite critics

© 2006 Nature Publishing Group

RODENT RISES FROMTHE DEADMammal is the livingrepresentative of a lineagepresumed extinct.www.nature.com/news

NATURE|Vol 440|16 March 2006 NEWS

263

Huge Biobank project launches despite criticsBritish family doctors have started recruitingsubjects for an ambitious effort to probe theinterplay of genetic and environmental factorsthat cause disease.

Researchers hope that half a million peoplewill donate blood and urine samples, and giveaccess to their medical records,as part of UK Biobank. This£61-million (US$105-million)project launched on 13 March,funded by the Medical ResearchCouncil and the Wellcome Trust.Critics question whether it willgive value for money. But the project’s orga-nizers say it has enormous research potential.

Participants will be weighed and measured,and answer questions on topics such as alcoholintake and family medical history. Details willbe held in a database and linked to records col-lected by the National Health Service (NHS).

Thousands of cases of conditions such asheart disease and cancer are likely to develop,

and researchers will be able to search the data-base for underlying genes and lifestyle choices.

Critics, including members of the House ofCommons Select Committee on Science andTechnology, say health records alone can be apoor guide to the conditions a person suffers

from. Medical journals haveasked whether enough cases ofdisease will develop for resultsto be statistically meaningful.In contrast to some othergenetic-database projects,however, critics are not con-

cerned about data-privacy and ethical issues.UK Biobank’s chief executive, Rory Collins,

an epidemiologist at the University of Oxford,says complaints stem in part from a misunder-standing of the scheme. It might make sense tostudy the families of ill people if disease geneswere the main target, he says, but they are not.

“The primary use will be to compare peoplewho develop disease with those that don’t,” he

says. Researchers will then be able to examinethe lifestyle and genetic factors that differenti-ate the two groups.

Collins estimates that scientists will want tostart mining the database in about ten years,when several thousand cases of diseases willhave emerged. He adds that changes in theNHS computer system should have made iteasier for scientists to use for research by then.

Access will be controlled by UK Biobank,which will vet applications and coordinategroups to minimize the cost of accessing sam-ples. These will be frozen and split betweentwo locations, to provide a back-up.

The UK project will be tracked in countrieswith similar schemes. Canada, Iceland andJapan have set up smaller biobanks. Workbegan in 2001 on a project in Estonia, wherethe government wants to collect genealogical,health and DNA data on a million citizens — itaims to have data on some 100,000 by 2009. ■

Jim Giles

“Complaints stem in part from amisunderstanding of the scheme.”

16.3 News 263 MH 14/3/06 9:52 AM Page 263

Nature Publishing Group ©2006